Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

Clinical Trials

SURMOUNT-4 was built to answer the stopping question, and it did

The regain trajectories, arm by arm, with the estimands named.

By Marguerite Vasseur·27 June 2026·3,092 words

Sponsored

Independent testing — Janoshik Analytical

HPLC purity and peptide content on submitted samples, with the method stated on the report.

janoshik.com →

Sponsored

GL Biochem (Shanghai) Ltd. — synthesis

The house that made the material an independent laboratory then measures. Shanghai, since 1998.

glbiochem.net →

Departments

All 14 →

The newsroom

Dispatches →

Most read

The reference desk

Trial data explorer

Every major incretin trial the Journal cites, with the population, the comparator, the duration, the primary endpoint,…

Vendor dossiers

All 20 →

Twenty companies whose names appear most often on the label, reported as businesses: a documented testing record, a correspondence log, a box setting out what we verified, and an ordering box giving lead times, minimum quantities and what to ask for. Ratings are the Journal’s own and are not for sale.

RankCompanyBaseEst.GradeReviewsPosture
1
Bachem Holding (Suzhou) Co., Ltd.
Suzhou2003A792Documented; consistent across the run
2
Shanghai ERP Biotechnology Co., Ltd.
Shanghai2018A832Technically strong; documentation lot-specific
3
Zhuhai Kerui Biotechnology Co., Ltd.
Zhuhai2016A804Cold chain exemplary; documentation complete
4
GL Biochem (Shanghai) Ltd.
Shanghai1998A2,048Institutional; sponsor relationship disclosed
5
Shanghai Sigma-Audley New Material Technology Co., Ltd.
Shanghai2018A−864Narrow catalogue; unusually complete documentation
6
Qingdao Saber Technology Pharmaceutical
Qingdao2017A−519Release testing per lot; two-signature certificates
7
Qingdao Sigma Chemical Co., Ltd.
Qingdao, ShandongA−716Regional stock; fastest transit in the directory
8
Flourishglobal Peptide Biotech (Chengdu) Co., Ltd.
Chengdu2019A−799Fastest correspondence; pre-dispatch photographs

On “In-use periods, and the ones nobody can give you

Hand hygiene before anything else is the single highest-yield step in every published account of technique in any setting, and it is the step most often skipped because it is the least visible.

T. Kaminski, Bydgoszcz

On “In-use periods, and the ones nobody can give you

Sharps disposal is not an afterthought and the article treats it as one. A rigid container, obtained before it is needed rather than after, is the whole of the advice, and it belongs at the start of the sequence rather than at the end.

T. Oyelowo, Abeokuta

On “In-use periods, and the ones nobody can give you

The unit confusion in this area is a design problem rather than an education problem. A syringe graduated for one purpose, used to measure a volume of something else, will produce errors at a rate determined by the markings and not by the diligence of the person reading them.

T. Wexford, Louisville, KY

On “In-use periods, and the ones nobody can give you

You recommend writing the concentration on the vial. I would add: write it on the box as well. My vial label came off in the fridge and I lost the only record of what diluent volume I had used.

M. Sandhu, Amritsar